PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Children0 citationsOpen Access

Endoscopic Hemostasis as a Bridge to Surgical Portal Decompression in Children with Portal Hypertensive Bleeding: A Staged Endoscopic–Surgical Strategy

View Full Paper
JXJianji XuJZJinshan ZhangCKChihuan Kong

Key Points

  • Evaluate clinical outcomes of endoscopic hemostasis and surgical portal decompression in children with portal hypertension-related bleeding.
  • Retrospective consecutive cohort study including 12 pediatric patients with portal hypertension-related variceal bleeding.
  • All patients underwent endoscopic hemostasis prior to evaluation for portal decompression surgery.
  • Clinical outcomes analyzed include hemostasis success, rebleeding, shunt patency, and mortality.
  • Endoscopic hemostasis was successfully achieved in all patients with no early rebleeding prior to surgery.
  • Ten patients underwent portal decompression surgery within 7 days post-hemostasis.
  • Early dysfunction was observed in 25% of younger children with Rex shunt, while older children showed no dysfunction.

Abstract

Background: Portal hypertension is a major cause of esophagogastric variceal bleeding in children. Endoscopic therapy is widely used for acute hemostasis; however, it primarily controls the bleeding episode rather than the underlying portal hypertensive physiology, and definitive management often requires surgical portal decompression. Evidence regarding the outcomes of a staged endoscopic–surgical management strategy in pediatric patients remains limited. This study aimed to evaluate the clinical outcomes of children with portal hypertensive bleeding managed with endoscopic hemostasis as a bridging therapy followed by definitive portal decompression surgery. Methods: We conducted a retrospective consecutive cohort study including 12 children presenting with portal hypertension-related variceal bleeding at our tertiary pediatric center between January 2021 and December 2024. All patients underwent endoscopic hemostasis, followed by evaluation for portal decompression surgery when anatomically feasible. Clinical outcomes including hemostasis success, rebleeding, shunt patency, and survival were analyzed. An age-stratified exploratory analysis was performed to examine the association with early dysfunction after Rex shunt reconstruction. Results: Endoscopic hemostasis was successfully achieved in all patients, with no early rebleeding prior to surgery. Ten patients underwent portal decompression surgery within 7 days (Rex shunt, n = 8; splenorenal shunt, n = 2). During a median follow-up of 18 months, early Rex shunt dysfunction (<3 months) was observed in 2 of 8 patients (25%), both of whom were younger than 3 years, whereas no dysfunction was observed in older children. Given the small sample size, this observation should be interpreted descriptively. Rebleeding and mortality occurred exclusively in association with shunt dysfunction. Conclusions: A staged endoscopic–surgical strategy appears feasible for stabilizing children with acute portal hypertensive bleeding and enabling timely definitive portal decompression. In this small cohort (n = 12), an age-related signal in early Rex shunt dysfunction was observed in very young children; however, this finding should be interpreted cautiously and requires further validation in larger studies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xu et al. (2026) studied this question.

synapsesocial.com/papers/69fa8e8904f884e66b530d86https://doi.org/10.3390/children13050624
Ask AI
Helpful
Bookmark
Share
View Full Paper